Palvella Therapeutics, Inc. (PVLA) Revenue 2014–2023
Palvella Therapeutics, Inc. (PVLA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$42.8MFY2023 · since FY2014: $5.4M → $42.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $42.8M | +65.3% |
| FY2022 | $25.9M | -17.6% |
| FY2021 | $31.4M | +7.1% |
| FY2020 | $29.3M | -32.8% |
| FY2019 | $43.6M | +60.2% |
| FY2018 | $27.2M | +7.8% |
| FY2017 | $25.3M | +333.5% |
| FY2016 | $5.8M | +98.9% |
| FY2015 | $2.9M | -45.4% |
| FY2014 | $5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice